Blueblood Ventures Ltd

Blueblood Ventures Ltd announced the Standalone Annual Audited Financial Results for the financial year ended March 31, 2026, along with an auditor's report with an unmodified opinion. The decision was made during the Board Meeting held on May 27, 2026, which commenced at 1:00 PM and concluded at 3:00 PM. Auditors KRA & Associates issued an audit report with an unmodified opinion.

Blueblood Ventures Ltd. has announced the approval of its standalone annual audited financial results for the financial year ended March 31, 2026, following a Board of Directors meeting held on May 27, 2026. The results, reviewed by the Audit Committee, include an auditor's report with an unmodified opinion from M/s KRA & Associates, Chartered Accountants. Emphasis of Matters include Zero Optional convertible debentures under non-Current investments Rs 1155.00 lakhs and Pending confirmations / statement of accounts / follow up documents of old debit balances of long-term loans and advances Rs 6346.28 lakhs.

Blueblood Ventures Ltd has announced that its Board of Directors will convene a meeting on Wednesday, May 27, 2026. The primary agenda for this meeting is to consider and approve the Audited Standalone Financial Results for the half and financial year ended March 31, 2026. In compliance with SEBI regulations, the trading window for designated persons and insiders has been closed since March 31, 2026, and is scheduled to re-open on May 30, 2026, following the board meeting.

Blueblood Ventures Limited has disclosed that neither the promoters nor the persons acting in concert (PAC) have made any encumbrance on the equity shares held in the company during the Financial Year ended March 31, 2026. Furthermore, as of March 31, 2026, no equity shares of Blueblood Ventures Limited are encumbered or pledged by the promoters or PAC.